Incidental Mutation 'IGL02553:Metap2'
ID 298568
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Metap2
Ensembl Gene ENSMUSG00000036112
Gene Name methionine aminopeptidase 2
Synonyms eIF-2-associated p67, 4930584B20Rik, A930035J23Rik, p67
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # IGL02553
Quality Score
Status
Chromosome 10
Chromosomal Location 93694351-93732952 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 93701311 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Methionine to Valine at position 165 (M165V)
Gene Model predicted gene model for transcript(s): [ENSMUST00000047910] [ENSMUST00000180688] [ENSMUST00000180840] [ENSMUST00000181091] [ENSMUST00000181470] [ENSMUST00000181217]
AlphaFold O08663
Predicted Effect probably benign
Transcript: ENSMUST00000047910
AA Change: M308V

PolyPhen 2 Score 0.095 (Sensitivity: 0.93; Specificity: 0.85)
SMART Domains Protein: ENSMUSP00000048285
Gene: ENSMUSG00000036112
AA Change: M308V

DomainStartEndE-ValueType
low complexity region 24 48 N/A INTRINSIC
low complexity region 77 108 N/A INTRINSIC
Pfam:Peptidase_M24 167 466 1.2e-47 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000180375
Predicted Effect probably damaging
Transcript: ENSMUST00000180392
AA Change: M165V

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
Predicted Effect probably benign
Transcript: ENSMUST00000180688
SMART Domains Protein: ENSMUSP00000137652
Gene: ENSMUSG00000036112

DomainStartEndE-ValueType
low complexity region 24 48 N/A INTRINSIC
low complexity region 76 107 N/A INTRINSIC
Pfam:Peptidase_M24 166 233 2e-14 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000180840
AA Change: M308V

PolyPhen 2 Score 0.095 (Sensitivity: 0.93; Specificity: 0.85)
SMART Domains Protein: ENSMUSP00000138006
Gene: ENSMUSG00000036112
AA Change: M308V

DomainStartEndE-ValueType
low complexity region 24 48 N/A INTRINSIC
low complexity region 77 108 N/A INTRINSIC
Pfam:Peptidase_M24 167 466 2.8e-50 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000181009
Predicted Effect possibly damaging
Transcript: ENSMUST00000181091
AA Change: M285V

PolyPhen 2 Score 0.805 (Sensitivity: 0.84; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000137904
Gene: ENSMUSG00000036112
AA Change: M285V

DomainStartEndE-ValueType
low complexity region 24 48 N/A INTRINSIC
low complexity region 77 108 N/A INTRINSIC
Pfam:Peptidase_M24 144 443 2.2e-50 PFAM
Predicted Effect possibly damaging
Transcript: ENSMUST00000181470
AA Change: M19V

PolyPhen 2 Score 0.882 (Sensitivity: 0.82; Specificity: 0.94)
SMART Domains Protein: ENSMUSP00000138050
Gene: ENSMUSG00000036112
AA Change: M19V

DomainStartEndE-ValueType
Pfam:Peptidase_M24 1 97 6.6e-15 PFAM
Predicted Effect possibly damaging
Transcript: ENSMUST00000181217
AA Change: M318V

PolyPhen 2 Score 0.805 (Sensitivity: 0.84; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000138083
Gene: ENSMUSG00000036112
AA Change: M318V

DomainStartEndE-ValueType
low complexity region 24 48 N/A INTRINSIC
low complexity region 77 108 N/A INTRINSIC
Pfam:Peptidase_M24 177 476 2.7e-50 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000181894
Predicted Effect noncoding transcript
Transcript: ENSMUST00000181442
Predicted Effect noncoding transcript
Transcript: ENSMUST00000216232
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a member of the methionyl aminopeptidase family. The encoded protein functions both by protecting the alpha subunit of eukaryotic initiation factor 2 from inhibitory phosphorylation and by removing the amino-terminal methionine residue from nascent proteins. Increased expression of this gene is associated with various forms of cancer, and the anti-cancer drugs fumagillin and ovalicin inhibit the protein by irreversibly binding to its active site. Inhibitors of this gene have also been shown to be effective for the treatment of obesity. A pseudogene of this gene is located on chromosome 2. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]
PHENOTYPE: Homozygous mutation of this gene results in embryonic lethality around E8.5, smaller size, failure to gastrulate, reduced cell proliferation and absence of a distinct mesoderm. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 59 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abcc3 A G 11: 94,242,750 (GRCm39) S1326P probably damaging Het
Alpk1 A T 3: 127,466,970 (GRCm39) L1103Q probably damaging Het
Arhgap11a A C 2: 113,667,906 (GRCm39) probably benign Het
Arl6ip6 A G 2: 53,082,226 (GRCm39) Y31C possibly damaging Het
Arpin G T 7: 79,577,395 (GRCm39) D217E possibly damaging Het
Atp13a4 C T 16: 29,241,521 (GRCm39) V735I probably benign Het
Ccdc146 A T 5: 21,502,631 (GRCm39) F753L probably benign Het
Cdh3 T A 8: 107,270,880 (GRCm39) L511* probably null Het
Chrna1 A T 2: 73,397,206 (GRCm39) I361N possibly damaging Het
Clk2 G A 3: 89,083,020 (GRCm39) R432H probably damaging Het
Col9a1 T C 1: 24,261,018 (GRCm39) probably benign Het
Cstf1 G T 2: 172,219,774 (GRCm39) R295L probably benign Het
Dsg2 A G 18: 20,725,467 (GRCm39) D526G probably damaging Het
Dsg4 T A 18: 20,595,577 (GRCm39) H593Q probably benign Het
Dysf T C 6: 84,107,109 (GRCm39) Y1171H possibly damaging Het
Erbb4 A G 1: 68,345,023 (GRCm39) L566P probably benign Het
Fam185a T A 5: 21,660,829 (GRCm39) D281E probably damaging Het
Fam185a T A 5: 21,634,839 (GRCm39) probably benign Het
Fam91a1 T A 15: 58,304,831 (GRCm39) probably null Het
Fat2 A G 11: 55,202,109 (GRCm39) W322R probably damaging Het
Fbxw8 T A 5: 118,204,125 (GRCm39) probably benign Het
Ganc A G 2: 120,288,615 (GRCm39) T874A probably benign Het
Gm3543 T C 14: 41,802,048 (GRCm39) I145M probably benign Het
Gtf2i G A 5: 134,274,015 (GRCm39) T712I probably damaging Het
Hk1 A G 10: 62,131,552 (GRCm39) S268P possibly damaging Het
Hmcn1 A G 1: 150,868,774 (GRCm39) V10A probably benign Het
Hsd17b4 C T 18: 50,295,164 (GRCm39) probably benign Het
Ighv1-75 A T 12: 115,797,725 (GRCm39) W66R probably damaging Het
Kif21b G T 1: 136,081,859 (GRCm39) D636Y probably damaging Het
Kif5b A T 18: 6,220,914 (GRCm39) I398N probably benign Het
Mterf2 A C 10: 84,956,331 (GRCm39) L98V probably damaging Het
Muc16 A G 9: 18,409,849 (GRCm39) probably null Het
Myo3b A G 2: 69,925,568 (GRCm39) M12V probably benign Het
Nat10 C A 2: 103,583,013 (GRCm39) R136I probably damaging Het
Nsd2 T G 5: 34,003,542 (GRCm39) S231A probably damaging Het
Or4a71 T C 2: 89,358,275 (GRCm39) T160A probably benign Het
Or4k37 A T 2: 111,159,333 (GRCm39) M190L probably benign Het
Pcdhb14 T A 18: 37,581,071 (GRCm39) L59* probably null Het
Pias4 A G 10: 80,999,621 (GRCm39) L144P probably damaging Het
Plxna2 T A 1: 194,433,746 (GRCm39) N598K probably benign Het
Polq A G 16: 36,862,130 (GRCm39) Y550C probably damaging Het
Pot1b T A 17: 56,002,024 (GRCm39) probably benign Het
Proz T C 8: 13,115,260 (GRCm39) V92A probably benign Het
Rab4a T C 8: 124,550,561 (GRCm39) F14L probably benign Het
Riok3 T A 18: 12,276,073 (GRCm39) C256* probably null Het
Slc6a1 T A 6: 114,279,451 (GRCm39) probably benign Het
Socs5 C T 17: 87,442,419 (GRCm39) T453M probably damaging Het
Spata3 T C 1: 85,952,211 (GRCm39) L135P probably damaging Het
Spata46 A G 1: 170,139,534 (GRCm39) K178E probably damaging Het
Spr T C 6: 85,114,430 (GRCm39) N100D probably damaging Het
Srrm4 C T 5: 116,582,624 (GRCm39) probably benign Het
Stard3 T C 11: 98,267,389 (GRCm39) F169S possibly damaging Het
Tbx1 T A 16: 18,402,847 (GRCm39) D222V probably damaging Het
Trbv23 C T 6: 41,193,279 (GRCm39) Q56* probably null Het
Tsc22d1 A G 14: 76,654,838 (GRCm39) N357S possibly damaging Het
Ugt1a6a C T 1: 88,066,811 (GRCm39) P206S probably benign Het
Utp20 A G 10: 88,600,657 (GRCm39) V19A probably damaging Het
Vps13b A G 15: 35,646,447 (GRCm39) N1517S probably benign Het
Washc2 T C 6: 116,218,571 (GRCm39) I672T probably damaging Het
Other mutations in Metap2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01671:Metap2 APN 10 93,707,340 (GRCm39) splice site probably benign
R0212:Metap2 UTSW 10 93,697,242 (GRCm39) missense probably damaging 1.00
R0749:Metap2 UTSW 10 93,715,429 (GRCm39) missense probably benign 0.43
R1183:Metap2 UTSW 10 93,706,046 (GRCm39) missense probably damaging 1.00
R1459:Metap2 UTSW 10 93,704,811 (GRCm39) missense probably damaging 1.00
R1468:Metap2 UTSW 10 93,707,345 (GRCm39) splice site probably null
R1468:Metap2 UTSW 10 93,707,345 (GRCm39) splice site probably null
R1646:Metap2 UTSW 10 93,706,059 (GRCm39) missense probably damaging 1.00
R3810:Metap2 UTSW 10 93,706,026 (GRCm39) nonsense probably null
R3811:Metap2 UTSW 10 93,706,026 (GRCm39) nonsense probably null
R3812:Metap2 UTSW 10 93,706,026 (GRCm39) nonsense probably null
R4174:Metap2 UTSW 10 93,715,427 (GRCm39) missense possibly damaging 0.68
R4801:Metap2 UTSW 10 93,704,757 (GRCm39) missense probably damaging 1.00
R4802:Metap2 UTSW 10 93,704,757 (GRCm39) missense probably damaging 1.00
R4983:Metap2 UTSW 10 93,725,462 (GRCm39) missense possibly damaging 0.86
R5030:Metap2 UTSW 10 93,715,539 (GRCm39) splice site probably null
R5276:Metap2 UTSW 10 93,704,794 (GRCm39) missense probably benign 0.02
R5276:Metap2 UTSW 10 93,704,784 (GRCm39) missense possibly damaging 0.93
R8191:Metap2 UTSW 10 93,701,267 (GRCm39) critical splice donor site probably null
R8311:Metap2 UTSW 10 93,697,384 (GRCm39) missense possibly damaging 0.71
R9622:Metap2 UTSW 10 93,707,366 (GRCm39) missense probably benign 0.02
Posted On 2015-04-16